Majority of cancer patients ‘still in remission’ following breakthrough Perth trial, page-4

''Recent reports on the cancer trial in Perth, Australia, led by Professor Chan Cheah, highlight significant achievements in the field of blood cancer research:
- **Breakthrough Trial Results**: A majority of cancer patients involved in a landmark clinical trial in Perth remain in remission years after receiving a breakthrough treatment. This trial has been pivotal in improving patient outcomes and demonstrates the effectiveness of the new therapeutic approaches being tested[4].
- **Recognition for Research Excellence**: Professor Chan Cheah, a Clinical Haematologist at Sir Charles Gairdner Hospital, was awarded the Cancer Council WA Researcher of the Year 2023. His work has significantly impacted blood cancer research, particularly in improving access to clinical trials and novel treatments for Western Australians[1][2].
- **Research Contributions**: Professor Cheah has been a leading figure in clinical research for lymphoma and chronic lymphocytic leukemia, contributing to over 150 peer-reviewed publications. His efforts have established one of the most successful haematology clinical research programs in Australia, delivering cutting-edge treatments before commercial availability[2][3].
Citations:
[1] https://cancerwa.asn.au/news/top-perth-blood-cancer-researcher-wins-prestigious-award/
[2] https://www.nmhs.health.wa.gov.au/News/2023/09/11/Professor-Chan-Cheah
[3] https://research-repository.uwa.edu.au/en/persons/chan-cheah
[4] https://thewest.com.au/news/health/...following-breakthrough-perth-trial-c-15699818
[5] https://www.bloodcancerwa.org.au/professor-chan-cheah/
[6] https://www.breakthroughhaematology.com.au/professor-chan-cheah/
[7] https://x.com/chanyooncheah
[8] https://www.hollywoodprivate.com.au...ood-private-hospital/haematology/104687/trees